ArticleJournal of Cancer2024

Development and validation of matrix metalloproteinase for predicting prognosis and tumour microenvironment immune profiles in uterine corpus endometrial carcinoma.

Huancheng Su et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.